Demyelinating Autoimmune Diseases, CNS
"Demyelinating Autoimmune Diseases, CNS" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.
| Descriptor ID |
D020278
|
| MeSH Number(s) |
C10.114.375 C10.228.140.695.562 C10.314.350 C20.111.258.250
|
| Concept/Terms |
Demyelinating Autoimmune Diseases, CNS- Demyelinating Autoimmune Diseases, CNS
- Demyelinating Autoimmune Disorders, CNS
- Demyelinating Disease, Autoimmune, CNS
- CNS Demyelinating Autoimmune Diseases
- Autoimmune Demyelinating Diseases, CNS
- Autoimmune Demyelinating Disorders, CNS
- CNS Autoimmune Demyelinating Disorders
- Demyelinating Autoimmune Diseases, Central Nervous System
- Autoimmune Demyelinating Diseases, Central Nervous System
|
Below are MeSH descriptors whose meaning is more general than "Demyelinating Autoimmune Diseases, CNS".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Autoimmune Diseases, CNS".
This graph shows the total number of publications written about "Demyelinating Autoimmune Diseases, CNS" by people in this website by year, and whether "Demyelinating Autoimmune Diseases, CNS" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Demyelinating Autoimmune Diseases, CNS" by people in Profiles.
-
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
-
High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist. J Neurol. 2019 12; 266(12):3160-3161.
-
Progressive solitary sclerosis presented with diplopia: A case report. Mult Scler Relat Disord. 2019 Feb; 28:129-131.
-
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018 05 22; 90(21):e1858-e1869.
-
Radiologically isolated syndrome should be treated with disease-modifying therapy - No. Mult Scler. 2017 12; 23(14):1820-1821.
-
Role of IFN-gamma responsiveness in CD8 T-cell-mediated viral clearance and demyelination in coronavirus-infected mice. J Neuroimmunol. 2008 Feb; 194(1-2):18-26.
-
Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J Immunol. 2002 Aug 01; 169(3):1550-5.